| (Values in U.S. Thousands) | Jun, 2017 | Jun, 2016 | Jun, 2015 | Jun, 2014 | Jun, 2013 |
| Sales | 3,220 | 2,560 | 260 | 0 | 0 |
| Sales Growth | +25.78% | +884.62% | unch | unch | unch |
| Net Income | -22,510 | -28,180 | -7,720 | -60 | -60 |
| Net Income Growth | +20.12% | -265.03% | -12,766.88% | unch | unch |
Aytu Bioscience Inc (AYTUD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Aytu BioScience, Inc. is a healthcare company which focused on commercialization of novel products in the field of urology. The company's marketed products consists of ProstaScint(R), Primsol(R) and MiOXSYS(TM) which addresses prostate cancer, urinary tract infections, male infertility and male sexual dysfunction. Aytu BioScience, Inc. is based in Englewood, Colorado.